About Naplasol
Naplasol is a company based in Bree (Belgium) founded in 2020. The company has 4 employees as of December 31, 2022. Naplasol has completed 1 acquisition, including Mycorena. Naplasol offers products and services including Mycoproteins and Fermented Mycoprotein Structures. Naplasol operates in a competitive market with competitors including Paleo, Alpro, Taaas and LIKE-A-PRO, among others.
- Headquarter Bree, Belgium
- Employees 4 as on 31 Dec, 2022
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Naplasol
-
Annual Revenue
Not available
-
Net Profit
-$1.88 M (USD)-3485as on Dec 31, 2022
-
EBITDA
-$1.17 M (USD)-2197as on Dec 31, 2022
-
Latest Funding Round
$1.56 M (USD), Grant
Sep 01, 2021
- Investors
-
Employee Count
4
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Naplasol
Naplasol offers a comprehensive portfolio of products and services, including Mycoproteins and Fermented Mycoprotein Structures.
Fermented fungal structures for high-protein plant-based food products
Nutrient-rich materials for meat replacers and food innovations
Funding Insights of Naplasol
Investors in Naplasol
Naplasol has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Naplasol
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Naplasol
Naplasol has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mycorena.
Investment portfolio details for Naplasol
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mycoprotein novel food is developed using fungi-based fermentation technology.
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Naplasol
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Naplasol
Detailed financials for Naplasol
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Naplasol Comparisons
Peer comparison for Naplasol
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Naplasol
Naplasol operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Paleo, Alpro, Taaas and LIKE-A-PRO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell-based alternative animal protein provider
|
|
| Locked | Locked | Locked |
Platform providing plant-based food
|
|
| Locked | Locked | Locked |
Provides technology for transforming plant-based ingredients into meat alternatives.
|
|
| Locked | Locked | Locked |
Develops alternative protein sources from plants, insects, and microbes for mainstream use.
|
Detailed competitors of Naplasol
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Naplasol
Complete news archive for Naplasol
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naplasol
Naplasol was founded in 2020.
Naplasol is headquartered in Bree, Belgium.
As of Dec 31, 2022, the latest employee count at Naplasol is 4.
Naplasol was founded in 2020 and is located in Bree, Belgium. Operations focus on the food sector, where plant-based meat alternatives are developed and supplied. Mycoprotein-based proteins are offered to create various plant-based food options. The company serves markets seeking sustainable protein sources, with activities centered on production and distribution from its Belgian base.
Naplasol offers Mycoproteins and Fermented Mycoprotein Structures.
Naplasol has made 1 acquisition, including Mycorena.
Naplasol has 1 investor. Key investors include European Union.